0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double blind, cross-over, placebo controlled trial

被引：0
|
作者：
Kulkantrakorn, K. [1 ]
Lorsuwansiri, C. [1 ]
Meesawatsom, P. [2 ]
机构：
[1] Thammasat Univ, Fac Med, Pathum Thani, Thailand
[2] Mahidol Univ, Fac Pharm, Bangkok 10700, Thailand
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: A double-blind, placebo controlled study
    Edwards, KR
    Glantz, MJ
    Button, J
    Norton, JA
    Whittaker, T
    Cross, N
    NEUROLOGY, 2000, 54 (07) : A81 - A81
  • [32] Methylphenidate for the treatment of gait impairment in Parkinson's disease: A randomized, double-blind, placebo-controlled cross-over trial
    Espay, A. J.
    Dwivedi, A. Kumar
    Savage, S.
    Gaines, L.
    Vaughan, J. E.
    Gartner, M.
    Sahay, A.
    Revilla, F. J.
    Duker, A. P.
    Shukla, R.
    MOVEMENT DISORDERS, 2010, 25 (07) : S295 - S296
  • [33] Alendronate Treatment for Juvenile Osteoporosis. A Double-Blind, Randomized, Placebo-controlled Cross-Over Clinical Trial.
    Key, L. L.
    Madyastha, P.
    Ries, W.
    Hollis, B.
    Reed, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S465 - S465
  • [34] DIPYRIDAMOLE FOR THE TREATMENT OF RLS: PRELIMINARY RESULTS OF A CROSS-OVER, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    Garcia-Borreguero, D.
    Granizo, J.
    Ferre, S.
    SLEEP, 2020, 43 : A303 - A303
  • [35] The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial
    Shin, S.
    Kim, K. J.
    Chang, H. -J.
    Lee, B. -W.
    Yang, W. -I.
    Cha, B. -S.
    Choi, D.
    DIABETES OBESITY & METABOLISM, 2013, 15 (02): : 185 - 188
  • [36] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [37] Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
    Segev, Aviv
    Evans, Anthony
    Hodsoll, John
    Whiskey, Eromona
    Sheriff, Rebecca S.
    Shergill, Sukhi
    MacCabe, James H.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 101 - 107
  • [38] Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial
    Shaibani, Aziz
    Fares, Salah
    Selam, Jean-Louis
    Arslanian, Armen
    Simpson, Jeffrey
    Sen, David
    Bongardt, Sabine
    JOURNAL OF PAIN, 2009, 10 (08): : 818 - 828
  • [39] Lorazepam for chronic catatonia: a randomized, double blind, placebo-controlled cross-over study
    Ungvari, GS
    Chiu, HFK
    Chow, LY
    Lau, BST
    Tang, WK
    PSYCHOPHARMACOLOGY, 1999, 142 (04) : 393 - 398
  • [40] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Roeske, Maxwell J.
    Mchugo, Maureen
    Rogers, Baxter
    Armstrong, Kristan
    Avery, Suzanne
    Donahue, Manus
    Heckers, Stephan
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (04) : 681 - 689
12345